BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/23/2022 12:48:56 AM | Browse: 225 | Download: 535
Publication Name World Journal of Hepatology
Manuscript ID 77971
Country United Kingdom
Received
2022-05-30 13:56
Peer-Review Started
2022-05-30 14:00
To Make the First Decision
Return for Revision
2022-07-13 22:55
Revised
2022-07-18 10:05
Second Decision
2022-08-08 03:09
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2022-08-18 00:11
Articles in Press
2022-08-18 00:11
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2022-08-19 02:33
Publish the Manuscript Online
2022-09-23 00:48
ISSN 1948-5182 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Minireviews
Article Title Bile acids as drivers and biomarkers of hepatocellular carcinoma
Manuscript Source Unsolicited Manuscript
All Author List Santo Colosimo and Jeremy W Tomlinson
ORCID
Author(s) ORCID Number
Santo Colosimo http://orcid.org/0000-0002-1724-498X
Jeremy W Tomlinson http://orcid.org/0000-0002-3170-8533
Funding Agency and Grant Number
Corresponding Author Jeremy W Tomlinson, FRCP, PhD, Professor, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, NIHR Oxford Biomedical Research Centre, Churchill Hospital, Oxford OX3 7LE, United Kingdom. jeremy.tomlinson@ocdem.ox.ac.uk
Key Words Bile acid; Liver cancer; Screening; Cirrhosis; Serum metabolites; Urine metabolites
Core Tip The rapidly increasing prevalence of hepatocellular carcinoma (HCC) highlights the unmet clinical need to develop and enhance early diagnostic strategies. Evidence from rodent and in vitro models suggests that bile acids may have a crucial role in the pathogenesis of HCC. Changes in circulating bile acid profiles are observed in patients with HCC. Serum and urine bile acid profiles may predict HCC risk and may have potential as a non-invasive screening tool.
Publish Date 2022-09-23 00:48
Citation Colosimo S, Tomlinson J. Bile acids as drivers and biomarkers of hepatocellular carcinoma. World J Hepatol 2022;14(9): 1730-1738
URL https://www.wjgnet.com/1948-5182/full/v14/i9/1730.htm
DOI https://dx.doi.org/10.4254/wjh.v14.i9.1730
Full Article (PDF) WJH-14-1730.pdf
Full Article (Word) WJH-14-1730.docx
Manuscript File 77971_Auto_Edited-LS.docx
Answering Reviewers 77971-Answering reviewers.pdf
Audio Core Tip 77971-Audio core tip.m4a
Conflict-of-Interest Disclosure Form 77971-Conflict-of-interest statement.pdf
Copyright License Agreement 77971-Copyright license agreement.pdf
Peer-review Report 77971-Peer-review(s).pdf
Scientific Misconduct Check 77971-Bing-Wang LL-2.png
Scientific Editor Work List 77971-Scientific editor work list.pdf